| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Chemotherapy resistanceO6 alkylguanine DNA alkyltransferaseAlkylating agents| 1 | 2003 | Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. | 
| + | - | nl | Pharmacol Rev 55(1):57-103 (2003) |
| 2 | 2008 | Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. |
| + | - | nl | Clin Pharmacol Ther 83(5):673-91 (2008) |
| 3 | 2009 | Understanding and circumventing resistance to anticancer monoclonal antibodies. |
| + | - | nl | MAbs 1(3):222-9 (2009) |
| 4 | 2008 | Mechanisms of chemoresistance to alkylating agents in malignant glioma. |
| + | - | nl | Clin Cancer Res 14(10):2900-8 (2008) |
| 5 | 2008 | Platinum resistance: the role of DNA repair pathways. |
| + | - | nl | Clin Cancer Res 14(5):1291-5 (2008) |
| 6 | 2008 | Gemcitabine resistance in pancreatic cancer: picking the key players. |
| + | - | nl | Clin Cancer Res 14(5):1284-5 (2008) |
| 7 | 2001 | Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. |
| + | - | nl | Clin Cancer Res 7(8):2168-81 (2001) |
| 8 | 2001 | Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair. |
| + | - | nl | Clin Cancer Res 7(3):454-61 (2001) |
| 9 | 2000 | Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic? |
| + | - | nl | Clin Cancer Res 6(8):2967-8 (2000) |
| 10 | 1990 | Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. |
| + | - | nl | Cancer Res 50(20):6449-54 (1990) |
| 11 | 1990 | Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. |
| + | - | nl | Cancer Res 50(19):6119-29 (1990) |
| 12 | 1963 | STUDIES RELATED TO MECHANISMS OF RESISTANCE TO BIOLOGICAL ALKYLATING AGENTS. | 
| + | - | nl | Cancer Res 23(-):1334-49 (1963) |
| 13 | 2010 | Molecular basis for therapy resistance. |
| + | - | nl | Mol Oncol 4(3):284-300 (2010) |
